Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-28

Clinical Trial Update: Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men [Phase 3]

View source ↗

Summary

Phase 3 trial updates the efficacy and safety of oral testosterone undecanoate in male hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Marius Pharmaceuticals | Conditions: Hypogonadism, Male | Phase 3 | Status: COMPLETED | Results posted: 2023-06-28